Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Alice Tomei
University of Miami School of Medicine, Department: Surgery
Should you be removed from our database? Contact us at [email protected]. Read more below.
Converge Biotech
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Tomei holds 100,000 options in Converge Biotech. Converge is a start-up company whose value cannot be readily determined through reference to public prices or other reasonable measures of fair market value. Dr. Tomei is an inventor of intellectual property (IP) used in the NIH-funded research. The IP is licensed to Converge, in which Dr. Tomei has the aforementioned financial interest.
Conformal islet encapsulation for transplantation at vascularized sites to allow physiological insulin secretion
Islet encapsulation may eliminate the need for lifelong immunosuppression in islet transplantation for type 1 diabetes increasing the applicability of islet transplantation to the more than three million adults and children with type 1 diabetes in the US. So far, traditional encapsulation procedures have not been effective in patients because of transport limitations of traditional capsules. Our novel encapsulation strategy - conformal coating - addresses all transport limitations and it is compatible with most devices for extrahepatic ITX and the unlimited source of insulin-secreting cells derived from stem cells. !
Filed on January 16, 2018.
Tell us what you know about Alice Tomei's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.